Updated
Reviewed by Vidhi Upadhyay
Europe Hyperbaric Oxygen Therapy Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$419.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $743.3 Mn | — | — |
| 2025 (base) | $779.7 Mn | +$36.4 Mn | — |
| 2026 (forecast) | $818.0 Mn | +$38.2 Mn | +4.9% |
| 2027 (forecast) | $858.0 Mn | +$40.1 Mn | +10% |
| 2028 (forecast) | $900.1 Mn | +$42.0 Mn | +15.4% |
| 2029 (forecast) | $944.2 Mn | +$44.1 Mn | +21.1% |
| 2030 (forecast) | $990.4 Mn | +$46.3 Mn | +27% |
| 2031 (forecast) | $1.04 Bn | +$48.5 Mn | +33.2% |
| 2032 (forecast) | $1.09 Bn | +$50.9 Mn | +39.8% |
| 2033 (forecast) | $1.14 Bn | +$53.4 Mn | +46.6% |
| 2034 (forecast) | $1.20 Bn | +$56.0 Mn | +53.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$1.61 Bn
Canada
$305.3 Mn
China
$284.8 Mn
Japan
$218.8 Mn
Germany
$142.5 Mn
France
$113.9 Mn
UK
$108.6 Mn
Italy
$100.3 Mn
Brazil
$91.5 Mn
Ecuador
$82.6 Mn
Saudi Arabia
$77.6 Mn
India
$78.8 Mn
Spain
$68.2 Mn
Mexico
$57.3 Mn
Australia
$46.5 Mn
New Zealand
$44.8 Mn
Russia
$42.9 Mn
South Africa
$22.9 Mn
UAE
$20.0 Mn
Egypt
$12.9 Mn
Philippines
$7.5 Mn
Hong Kong
$5.9 Mn
Malaysia
$5.4 Mn
Thailand
$5.2 Mn
Singapore
$5.1 Mn
Kenya
$2.9 Mn
| Market size, 2025 | $779.7 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.20 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Sechrist Industries, Perry Baromedical, Oxy Health, Fink Engineering, ETC BioMedical Systems (see all) |
| Regulator in Europe | EU MDRSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Hyperbaric oxygen therapy has patients breathe pure oxygen in a pressurised chamber to help wounds heal and treat certain conditions.
Key segments of the hyperbaric Oxygen Therapy market include product (Monoplace Chambers, Multiplace Chambers and Portable Chambers) and application (Wound Healing, Decompression Sickness and Wellness and Longevity).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hyperbaric Oxygen Therapy market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the hyperbaric Oxygen Therapy market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the hyperbaric Oxygen Therapy market.
The hyperbaric Oxygen Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.[1] In the countries we cover here, medical devices are regulated by ANSM (France)[2], BfArM (Germany)[3], Ministry of Health (Italy)[4], Roszdravnadzor (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[8]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Ministry of Health. Checked 14 Nov 2026.
[5] Roszdravnadzor. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Commission, health technology assessment. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hyperbaric Oxygen Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.
What doctors and scientists are doing in Hyperbaric Oxygen Therapy right now, from free public sources.
| Country | Value | Year |
|---|---|---|
| France | 22.5 | 2025 |
| Germany | 23.7 | 2025 |
| Italy | 25.1 | 2025 |
| Russia | 17.8 | 2025 |
| Spain | 21.6 | 2025 |
| UK | 19.7 | 2025 |
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe
Europe
Europe
Europe
Europe
Europe
Pharmaceuticals · Europe
Healthcare Services · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Healthcare Services · Europe
Healthcare Services · Europe